MBXFX | PBAKX | MBXFX / PBAKX | |
Total Expense Ratio | 3.03 | 0.63 | 481% |
Annual Report Gross Expense Ratio | 3.03 | 0.64 | 473% |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 3.361 | 6.326 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.45B | 3.68B | 230% |
Annual Yield % from dividends | 1.12 | 0.00 | - |
Returns for 1 year | 4.26 | 8.29 | 51% |
Returns for 3 years | 5.28 | 24.09 | 22% |
Returns for 5 years | N/A | 30.85 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFEIX | 57.85 | 0.37 | +0.64% |
American Century Large Cap Equity I | |||
TRHZX | 175.30 | 0.92 | +0.53% |
T. Rowe Price Equity Index 500 Z | |||
LRSVX | 20.85 | 0.10 | +0.48% |
Lord Abbett Small Cap Value R6 | |||
RYBOX | 65.00 | 0.25 | +0.39% |
Rydex Biotechnology A | |||
MXECX | 11.46 | 0.02 | +0.17% |
Empower Core Strategies Intl Eq Instl |